economie10 %Sanofi faces a potential fine of up to 10% of its global revenue✓ Confirmed · 5 sources

EU investigates Sanofi for alleged anti-competitive practices

The European Commission suspects Sanofi of anti-competitive practices in the pharmaceutical market.

Published 6sem5 sources✓ ConfirmedMajorupdated 6sem

≈ 18sSpeed

The fact

The investigation focuses on strategies to delay the entry of generic drugs in Europe.

Sanofi faces a potential fine of up to 10% of its global revenue.

5 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 5 media sources · identified on June 26, 2026